Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Trend: Rethinking (and treating) chronic pain as a brain disease

Can stim­u­lat­ing the brain treat chron­ic pain? (Sci­ence Dai­ly):

We’ve pub­lished numer­ous brain stim­u­la­tion papers over sev­er­al years, and we always learn some­thing impor­tant,” said senior author Flavio Frohlich, PhD, direc­tor of the Car­oli­na Cen­ter for Neu­rostim­u­la­tion and asso­ciate pro­fes­sor of psy­chi­a­try. “But this is the first time we’ve stud­ied chron­ic pain, and this is the only time all three ele­ments of a study lined up per­fect­ly. We suc­cess­ful­ly tar­get­ed a spe­cif­ic brain region, we enhanced or restored that region’s activ­i­ty, and we cor­re­lat­ed that enhance­ment with a sig­nif­i­cant decrease in symp­toms” Keep on read­ing

Neurotechnology pioneers, please design with the end-user in mind

John Kemp, Pres­i­dent & CEO at The Vis­car­di Cen­ter and The Hen­ry Vis­car­di School in New York

_____

The impor­tance of being seen, heard and under­stood for neu­rotech­nol­o­gy end-users (Cen­ter for Neu­rotech­nol­o­gy at Uni­ver­si­ty of Wash­ing­ton):

Today, when real­is­tic-look­ing pros­thet­ic hands with artic­u­lat­ing fin­gers are becom­ing more wide­ly avail­able, one of the first things many peo­ple notice about John Kemp is that he choos­es to use pros­thet­ic met­al clamps instead of hands.

These don’t look func­tion­al,” Kemp said, hold­ing up his clamps. “They’re high­ly func­tion­al. I wear these all day. Read the rest of this entry »

FDA clears MindMaze GO neurorehabilitation platform, easing access to continued outpatient therapy

___

Mind­Maze Con­sol­i­dates First-ever FDA Approval for Inpa­tient and Out­pa­tient Neu­rore­ha­bil­i­ta­tion Ther­a­py (press release):

Mind­Maze, a leader in brain­tech, has today announced that it has obtained FDA clear­ance to launch its portable neu­rore­ha­bil­i­ta­tion prod­uct, Mind­Mo­tion™ GO, in the Unit­ed States. Togeth­er with Mind­Mo­tion PRO (which received FDA clear­ance in 2017), Mind­Mo­tion GO is the next offer­ing in the company’s con­tin­u­um of care, pro­vid­ing gam­i­fied neu­rore­ha­bil­i­ta­tion ther­a­py. Read the rest of this entry »

Occupational therapy study: Improving processing speed seen as key target to help patients with multiple sclerosis

.

Decreased Activ­i­ty Lev­els in MS Patients Linked To Cog­ni­tive Impair­ment (Mul­ti­ple Scle­ro­sis News):

A new study pub­lished in the Amer­i­can Jour­nal of Occu­pa­tion­al Ther­a­py assessed the cog­ni­tive fac­tors affect­ed in mul­ti­ple scle­ro­sis patients con­cern­ing their activ­i­ty and par­tic­i­pa­tion in every­day life Read the rest of this entry »

Invest in Brain Health to Drive Innovation and Prosperity

In an increas­ing­ly knowl­edge-based and inno­va­tion-dri­ven econ­o­my, human brains—not finan­cial capital—are becom­ing the pri­ma­ry dri­vers of busi­ness suc­cess. Engaged, cre­ative cit­i­zens and work­ers mean the dif­fer­ence between suc­cess and fail­ure at the orga­ni­za­tion­al and soci­etal lev­els.

Look­ing at the prob­lem from the per­spec­tive of brain health, there are Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

twitter_logo_header
RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.